Cancer BiologybioRxivPreprint
Functional orthogonality of WRN inhibitor resistance enables alternating therapy and mutation-tolerant inhibitor design in MSI-H cancers
Guizhen Zhou, Dan Teng, Dan Wang…·Mingyue Zheng
This study shows that resistance to different WRN inhibitors in MSI-H cancers creates orthogonal vulnerabilities, enabling alternating therapy and mutation-tolerant inhibitor design.
DOI 10.64898/2026.06.09.731233